Zonisamide vs placebo
Zonisamide probably leads to higher 50% responder rate (whole treatment period; any dose) compared with placebo (moderate certainty).
- RR 1.86 [1.6, 2.17]7 studies · 1429 participantsModerate
Zonisamide probably leads to higher 50% responder rate (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher withdrawal rates (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide may leads to higher adverse effects: ataxia (whole treatment period; any dose) compared with placebo (low certainty).
Zonisamide probably leads to higher adverse effects: dizziness (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: fatigue (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: nausea (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: somnolence (whole treatment period; any dose) compared with placebo (moderate certainty).
It is very uncertain whether zonisamide changes functional abilities Change in TRS part B score (motor tasks) Change… compared with placebo (very low certainty).
It is very uncertain whether zonisamide changes study withdrawal for any reason Number of participants withdrawn… compared with placebo (very low certainty).
It is very uncertain whether zonisamide changes adverse events Number of adverse events compared with placebo (very low certainty).